Trial Profile

A head-to-head comparison of Paclical with Abraxane in women with metastatic breast cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Advanced breast cancer
Focus Pharmacokinetics
Sponsors Oasmia Pharmaceutical

Most Recent Events

20 Aug 2019 Results published in the Advances in Therapy
05 Nov 2015 Final results published in an Oasmia Pharmaceutical media release.
05 Nov 2015 Status changed from active, no longer recruiting to completed, according to an Oasmia Pharmaceutical media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com